Optimizing DAPT Duration in High-Risk Patients After Coronary Stent Implantation: Bleeding Risk Takes It All

Affiliations

¹ Intensive Cardiac Care Unit and Cardiology Department, Centre Hospitalier Regional Universitaire de Tours & Tours University, Loire Valley Cardiovascular Collaboration, Tours, France. Electronic address: d.angoulvant@chu-tours.fr.
² Intensive Cardiac Care Unit and Cardiology Department, Centre Hospitalier Regional Universitaire de Tours & Tours University, Loire Valley Cardiovascular Collaboration, Tours, France.

Free article

Editorial

Denis Angoulvant et al. J Am Coll Cardiol. 2019.

Free article

. 2019 Feb 26;73(7):755-757.

doi: 10.1016/j.jacc.2018.11.047.

¹ Intensive Cardiac Care Unit and Cardiology Department, Centre Hospitalier Regional Universitaire de Tours & Tours University, Loire Valley Cardiovascular Collaboration, Tours, France. Electronic address: d.angoulvant@chu-tours.fr.
² Intensive Cardiac Care Unit and Cardiology Department, Centre Hospitalier Regional Universitaire de Tours & Tours University, Loire Valley Cardiovascular Collaboration, Tours, France.

No abstract available

Keywords: bleeding risk; dual antiplatelet therapy; ischemic risk; prediction score.

Comment on

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
Costa F, Van Klaveren D, Feres F, James S, Räber L, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. J Am Coll Cardiol. 2019 Feb 26;73(7):741-754. doi: 10.1016/j.jacc.2018.11.048. J Am Coll Cardiol. 2019. PMID: 30784667